ALSTOM (AOMD.DE) Fundamental Analysis & Valuation

FRA:AOMD • FR0010220475

Current stock price

23.21 EUR
-1.99 (-7.9%)
Last:

This AOMD.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AOMD.DE Profitability Analysis

1.1 Basic Checks

  • AOMD had positive earnings in the past year.
  • In the past year AOMD had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AOMD reported negative net income in multiple years.
  • In multiple years AOMD reported negative operating cash flow during the last 5 years.
AOMD.DE Yearly Net Income VS EBIT VS OCF VS FCFAOMD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B 3B

1.2 Ratios

  • With a Return On Assets value of 0.92%, AOMD is not doing good in the industry: 66.98% of the companies in the same industry are doing better.
  • With a Return On Equity value of 3.03%, AOMD is not doing good in the industry: 63.21% of the companies in the same industry are doing better.
  • The Return On Invested Capital of AOMD (3.50%) is worse than 64.15% of its industry peers.
  • AOMD had an Average Return On Invested Capital over the past 3 years of 2.36%. This is significantly below the industry average of 8.58%.
  • The last Return On Invested Capital (3.50%) for AOMD is above the 3 year average (2.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.92%
ROE 3.03%
ROIC 3.5%
ROA(3y)-0.31%
ROA(5y)-0.39%
ROE(3y)-1.2%
ROE(5y)-1.48%
ROIC(3y)2.36%
ROIC(5y)1.96%
AOMD.DE Yearly ROA, ROE, ROICAOMD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.68%, AOMD is doing worse than 63.21% of the companies in the same industry.
  • AOMD's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 4.01%, AOMD is not doing good in the industry: 62.26% of the companies in the same industry are doing better.
  • AOMD's Operating Margin has declined in the last couple of years.
  • AOMD has a worse Gross Margin (12.59%) than 95.28% of its industry peers.
  • In the last couple of years the Gross Margin of AOMD has declined.
Industry RankSector Rank
OM 4.01%
PM (TTM) 1.68%
GM 12.59%
OM growth 3Y69.79%
OM growth 5Y-11.95%
PM growth 3YN/A
PM growth 5Y-32.37%
GM growth 3Y3.78%
GM growth 5Y-6.9%
AOMD.DE Yearly Profit, Operating, Gross MarginsAOMD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. AOMD.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AOMD is destroying value.
  • Compared to 1 year ago, AOMD has more shares outstanding
  • AOMD has more shares outstanding than it did 5 years ago.
  • AOMD has a better debt/assets ratio than last year.
AOMD.DE Yearly Shares OutstandingAOMD.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
AOMD.DE Yearly Total Debt VS Total AssetsAOMD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 0.91, we must say that AOMD is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of AOMD (0.91) is worse than 77.36% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that AOMD is not too dependend on debt financing.
  • AOMD has a Debt to Equity ratio of 0.31. This is comparable to the rest of the industry: AOMD outperforms 50.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACC0.5
WACC7.03%
AOMD.DE Yearly LT Debt VS Equity VS FCFAOMD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B 8B 10B

2.3 Liquidity

  • AOMD has a Current Ratio of 0.97. This is a bad value and indicates that AOMD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.97, AOMD is doing worse than 87.74% of the companies in the same industry.
  • AOMD has a Quick Ratio of 0.97. This is a bad value and indicates that AOMD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.74, AOMD is not doing good in the industry: 75.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.74
AOMD.DE Yearly Current Assets VS Current LiabilitesAOMD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AOMD.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 208.61% over the past year.
  • The earnings per share for AOMD have been decreasing by -29.24% on average. This is quite bad
  • Looking at the last year, AOMD shows a small growth in Revenue. The Revenue has grown by 4.58% in the last year.
  • Measured over the past years, AOMD shows a quite strong growth in Revenue. The Revenue has been growing by 17.65% on average per year.
EPS 1Y (TTM)208.61%
EPS 3YN/A
EPS 5Y-29.24%
EPS Q2Q%275.83%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y6.12%
Revenue growth 5Y17.65%
Sales Q2Q%3.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.96% on average over the next years. This is quite good.
  • AOMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.33% yearly.
EPS Next Y26.58%
EPS Next 2Y24.16%
EPS Next 3Y19.88%
EPS Next 5Y13.96%
Revenue Next Year3.39%
Revenue Next 2Y4.35%
Revenue Next 3Y4.51%
Revenue Next 5Y4.33%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AOMD.DE Yearly Revenue VS EstimatesAOMD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
AOMD.DE Yearly EPS VS EstimatesAOMD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

3

4. AOMD.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 34.13, the valuation of AOMD can be described as expensive.
  • 63.21% of the companies in the same industry are cheaper than AOMD, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, AOMD is valued a bit more expensive.
  • Based on the Price/Forward Earnings ratio of 10.62, the valuation of AOMD can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, AOMD is valued cheaper than 80.19% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, AOMD is valued rather cheaply.
Industry RankSector Rank
PE 34.13
Fwd PE 10.62
AOMD.DE Price Earnings VS Forward Price EarningsAOMD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • AOMD's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.92
AOMD.DE Per share dataAOMD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • AOMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • AOMD's earnings are expected to grow with 19.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y24.16%
EPS Next 3Y19.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. AOMD.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.03%, AOMD has a reasonable but not impressive dividend return.
  • AOMD's Dividend Yield is a higher than the industry average which is at 1.64.
  • AOMD's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.03%

5.2 History

  • The dividend of AOMD decreases each year by -59.58%.
Dividend Growth(5Y)-59.58%
Div Incr Years0
Div Non Decr Years0
AOMD.DE Yearly Dividends per shareAOMD.DE Yearly Dividends per shareYearly Dividends per share 2017 2021 2022 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 11.39% of the earnings are spent on dividend by AOMD. This is a low number and sustainable payout ratio.
DP11.39%
EPS Next 2Y24.16%
EPS Next 3Y19.88%
AOMD.DE Yearly Income VS Free CF VS DividendAOMD.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B 3B
AOMD.DE Dividend Payout.AOMD.DE Dividend Payout, showing the Payout Ratio.AOMD.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AOMD.DE Fundamentals: All Metrics, Ratios and Statistics

ALSTOM

FRA:AOMD (4/9/2026, 7:00:00 PM)

23.21

-1.99 (-7.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-20
Earnings (Next)05-13
Inst Owners69.42%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap10.72B
Revenue(TTM)18.77B
Net Income(TTM)316.00M
Analysts71.82
Price Target26.51 (14.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.03%
Yearly Dividend0.06
Dividend Growth(5Y)-59.58%
DP11.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)7.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE 34.13
Fwd PE 10.62
P/S 0.57
P/FCF N/A
P/OCF 28
P/B 1.03
P/tB N/A
EV/EBITDA 8.92
EPS(TTM)0.68
EY2.93%
EPS(NY)2.19
Fwd EY9.42%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)0.83
OCFY3.57%
SpS40.63
BVpS22.55
TBVpS-1.17
PEG (NY)1.28
PEG (5Y)N/A
Graham Number18.57
Profitability
Industry RankSector Rank
ROA 0.92%
ROE 3.03%
ROCE 4.97%
ROIC 3.5%
ROICexc 3.6%
ROICexgc 14.09%
OM 4.01%
PM (TTM) 1.68%
GM 12.59%
FCFM N/A
ROA(3y)-0.31%
ROA(5y)-0.39%
ROE(3y)-1.2%
ROE(5y)-1.48%
ROIC(3y)2.36%
ROIC(5y)1.96%
ROICexc(3y)2.46%
ROICexc(5y)2.07%
ROICexgc(3y)19.81%
ROICexgc(5y)25.47%
ROCE(3y)3.35%
ROCE(5y)2.78%
ROICexgc growth 3Y15.87%
ROICexgc growth 5Y-22.05%
ROICexc growth 3Y72.68%
ROICexc growth 5Y-24.96%
OM growth 3Y69.79%
OM growth 5Y-11.95%
PM growth 3YN/A
PM growth 5Y-32.37%
GM growth 3Y3.78%
GM growth 5Y-6.9%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 2.04
Cap/Depr 58.83%
Cap/Sales 2.63%
Interest Coverage 250
Cash Conversion 24.07%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.74
Altman-Z 0.91
F-Score8
WACC7.03%
ROIC/WACC0.5
Cap/Depr(3y)53.94%
Cap/Depr(5y)55.69%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)208.61%
EPS 3YN/A
EPS 5Y-29.24%
EPS Q2Q%275.83%
EPS Next Y26.58%
EPS Next 2Y24.16%
EPS Next 3Y19.88%
EPS Next 5Y13.96%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y6.12%
Revenue growth 5Y17.65%
Sales Q2Q%3.24%
Revenue Next Year3.39%
Revenue Next 2Y4.35%
Revenue Next 3Y4.51%
Revenue Next 5Y4.33%
EBIT growth 1Y32.57%
EBIT growth 3Y80.18%
EBIT growth 5Y3.59%
EBIT Next Year112.41%
EBIT Next 3Y36.96%
EBIT Next 5Y23.55%
FCF growth 1Y87.6%
FCF growth 3YN/A
FCF growth 5Y17.8%
OCF growth 1Y183.99%
OCF growth 3YN/A
OCF growth 5Y14.6%

ALSTOM / AOMD.DE Fundamental Analysis FAQ

What is the fundamental rating for AOMD stock?

ChartMill assigns a fundamental rating of 3 / 10 to AOMD.DE.


What is the valuation status for AOMD stock?

ChartMill assigns a valuation rating of 3 / 10 to ALSTOM (AOMD.DE). This can be considered as Overvalued.


What is the profitability of AOMD stock?

ALSTOM (AOMD.DE) has a profitability rating of 2 / 10.


What are the PE and PB ratios of ALSTOM (AOMD.DE) stock?

The Price/Earnings (PE) ratio for ALSTOM (AOMD.DE) is 34.13 and the Price/Book (PB) ratio is 1.03.


What is the financial health of ALSTOM (AOMD.DE) stock?

The financial health rating of ALSTOM (AOMD.DE) is 1 / 10.